Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young WomenINSINGA, Ralph P; PEREZ, Gonzalo; ELBASHA, Elamin H et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 6, pp 1585-1594, issn 1055-9965, 10 p.Article

Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionHAUPT, Richard M; WHEELER, Cosette M; RADLEY, David R et al.International journal of cancer (Print). 2011, Vol 129, Num 11, pp 2632-2642, issn 0020-7136, 11 p.Article

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 YearsBROWN, Darron R; KJAER, Susanne K; AULT, Kevin A et al.The Journal of infectious diseases. 2009, Vol 199, Num 7, pp 926-935, issn 0022-1899, 10 p.Article

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 YearsWHEELER, Cosette M; KJAER, Susanne K; AULT, Kevin A et al.The Journal of infectious diseases. 2009, Vol 199, Num 7, pp 936-944, issn 0022-1899, 9 p.Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, H1-H31, SUP7Article

Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection ClearanceINSINGA, Ralph P; PEREZ, Gonzalo; BROWN, Darron R et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 2, pp 287-296, issn 1055-9965, 10 p.Article

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccineJOURA, Elmar A; KJAER, Susanne K; GARCIA, Patricia et al.Vaccine. 2008, Vol 26, Num 52, pp 6844-6851, issn 0264-410X, 8 p.Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, I1-I31, SUP8Article

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccineAULT, Kevin A; JOURA, Elmar A; TANG, Grace W. K et al.International journal of cancer (Print). 2011, Vol 128, Num 6, pp 1344-1353, issn 0020-7136, 10 p.Article

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesGARLAND, Suzanne M; HERNANDEZ-AVILA, Mauricio; TADDEO, Frank J et al.The New England journal of medicine. 2007, Vol 356, Num 19, pp 1928-1943, issn 0028-4793, 16 p.Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, F1-F31, SUP5Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesXAVIER BOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, G1-G31, SUP6Article

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young WomenMUNOZ, Nubia; KJAER, Susanne K; GARCIA, Patricia J et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 5, pp 325-339, issn 0027-8874, 15 p.Article

Natural History of Genital Warts : Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) VaccineGARLAND, Suzanne M; STEBEN, Marc; SINGS, Heather L et al.The Journal of infectious diseases. 2009, Vol 199, Num 6, pp 805-814, issn 0022-1899, 10 p.Article

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6,11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions : a combined analysis of three randomised clinical trialsJOURA, Elmar A; LEODOLTER, Sepp; STEBEN, Marc et al.Lancet (British edition). 2007, Vol 369, Num 9574, pp 1693-1702, issn 0140-6736, 10 p.Article

Neonatal herpes simplex virus infections in Canada : Results of a 3-year national prospective studyKROPP, Rhonda Y; WONG, Thomas; CORMIER, Louise et al.Pediatrics (Evanston). 2006, Vol 117, Num 6, pp 1955-1962, issn 0031-4005, 8 p.Article

Education, training, and communication for HPV vaccinesSHERRIS, Jacqueline; FRIEDMAN, Allison; WITTET, Scott et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.210-S3.218Article